Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

• Главные авторы: Chukiat Sirivichayakul (Автор), Pornthep Chanthavanich (Автор), Kriengsak Limkittikul (Автор), Claire-Anne Siegrist (Автор), Wassana Wijagkanalan (Автор), Pailinrut Chinwangso (Автор), Jean Petre (Автор), Pham Hong Thai (Автор), Mukesh Chauhan (Автор), Simonetta Viviani (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: An acellular Pertussis (aP) vaccine containing recombinant genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and Pertactin (PRN) has been developed by BioNet-Asia (BioNet). We present here the results of the first clinical study of this recombinant aP vaccin...